UiPathPATH
PATH
About: UiPath offers an end-to-end cross-application enterprise automation platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.
Employees: 4,035
0
Funds holding %
of 7,419 funds
0
Analysts bullish %
of 11 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
96% more first-time investments, than exits
New positions opened: 100 | Existing positions closed: 51
10% more funds holding
Funds holding: 412 [Q3] → 452 (+40) [Q4]
1.86% more ownership
Funds ownership: 63.65% [Q3] → 65.51% (+1.86%) [Q4]
2% more capital invested
Capital invested by funds: $3.81B [Q3] → $3.89B (+$87.1M) [Q4]
1% more call options, than puts
Call options by funds: $146M | Put options by funds: $145M
13% less repeat investments, than reductions
Existing positions increased: 135 | Existing positions reduced: 155
25% less funds holding in top 10
Funds holding in top 10: 12 [Q3] → 9 (-3) [Q4]
Research analyst outlook
11 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$10
4%
downside
Avg. target
$11.68
12%
upside
High target
$14
34%
upside
11 analyst ratings
1 positive
9%
8 neutral
73%
2 negative
18%
Mizuho Siti Panigrahi 15% 1-year accuracy 5 / 33 met price target | 5%upside $11 | Neutral Maintained | 15 Apr 2025 |
RBC Capital Matthew Hedberg 53% 1-year accuracy 109 / 206 met price target | 24%upside $13 | Sector Perform Reiterated | 26 Mar 2025 |
BMO Capital Keith Bachman 42% 1-year accuracy 24 / 57 met price target | 10%upside $11.50 | Market Perform Maintained | 14 Mar 2025 |
Canaccord Genuity Kingsley Crane 29% 1-year accuracy 9 / 31 met price target | 34%upside $14 | Buy Maintained | 13 Mar 2025 |
Evercore ISI Group Kirk Materne 23% 1-year accuracy 5 / 22 met price target | 15%upside $12 | In-Line Maintained | 13 Mar 2025 |
Financial journalist opinion
Based on 17 articles about PATH published over the past 30 days
Positive
Zacks Investment Research
1 day ago
Here is What to Know Beyond Why UiPath, Inc. (PATH) is a Trending Stock
UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Neutral
Seeking Alpha
6 days ago
UiPath's Oversold Status Triggers Cheap Buying Opportunity - Maintain Buy
UiPath's kitchen sink FY2026 guidance has triggered growth concerns after the robust 3Y top/bottom-line performance, with it contributing to the massive selloff thus far. This is worsened by the potentially impacted SaaS demand in both federal and commercial end markets, attributed to the DOGE headwinds and higher recessionary risks. Even so, given the still rich Free Cash Flow generation, robust balance sheet, and the growing ARR, we believe that PATH remains well positioned to outperform from current discounted levels.
Neutral
Business Wire
6 days ago
UiPath Recognized as a Leader in the Everest Group Intelligent Document Processing (IDP) Products PEAK Matrix® Assessment 2025
NEW YORK--(BUSINESS WIRE)--UiPath has been named a Leader in Intelligent Document Processing in the Everest Group IDP Products PEAK Matrix® Assessment 2025.
Positive
The Motley Fool
6 days ago
3 Monster Stocks to Hold for the Next 10 Years
The best way to grow your wealth and better prepare yourself for retirement is to invest your money in promising stocks. Growth stocks are a great bet for the future and can help you increase the value of your portfolio over time.
Positive
Zacks Investment Research
1 week ago
Earnings Estimates Rising for UiPath (PATH): Will It Gain?
UiPath (PATH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Positive
Seeking Alpha
1 week ago
UiPath: Ignore The Bearish Noise And Buy This AI Gem
Despite a 20% stock decline, we maintain a bullish view on UiPath due to its strategic pivot to Agentic AI and strong customer retention. PATH leads the growing RPA market, with robust demand and a competitive edge through ML, NLP, and intelligent document processing capabilities. The company's aggressive push into Agentic AI, including new features like autopilot and agent builder, positions it well in the expanding AI market.
Positive
Zacks Investment Research
1 week ago
AppLovin vs. UiPath: Which AI-Driven Tech Stock is a Better Buy?
Both APP and PATH are technology companies leveraging artificial intelligence to enhance their platforms. Which one is a better investment?
Neutral
Business Wire
1 week ago
UiPath Announces AI Partnership with Google Cloud to Transform Medical Processes
NEW YORK & LAS VEGAS--(BUSINESS WIRE)--UiPath announced the launch of its generative AI-based UiPath Medical Record Summarization agent, powered by Google Cloud Vertex AI and Gemini models.
Positive
Zacks Investment Research
2 weeks ago
UiPath, Inc. (PATH) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Positive
Seeking Alpha
2 weeks ago
UiPath: This Market Carnage Is A Perfect Time To Buy This Stock Cheaply
UiPath's stock has dropped ~20% since January, presenting a buying opportunity for long-term investors, despite macroeconomic concerns and disappointing Q4 results. UiPath focuses on agentic automation, boasts a large ARR base, and has high gross margins, making it a strong AI investment. The stock is one of few software companies to trade at just ~2x revenue and ~10x FCF.
Charts implemented using Lightweight Charts™